Evidence-Based Benefits
- Liver enzyme reduction — Ip et al. (1996) demonstrated that schisandrin B significantly reduced elevated ALT and AST in carbon tetrachloride-induced liver injury models, with protective effects comparable to silymarin at equivalent doses.
- Detoxification enzyme enhancement — schisandra lignans induce both Phase I (CYP450) and Phase II (glutathione S-transferase, UDP-glucuronosyltransferase) enzymes, accelerating the metabolism and clearance of toxins and drugs from the liver (Panossian & Wikman, 2008).
- Hepatocyte membrane stabilization — schisandrin B protects liver cell membranes from lipid peroxidation and reduces oxidative damage by increasing hepatic glutathione (GSH) levels (Ko et al., 1995).
- Anti-inflammatory effects — schisandra lignans inhibit NF-κB-mediated inflammatory signaling in hepatocytes, reducing TNF-α and IL-6 production in liver tissue (Guo et al., 2008).
- Liver regeneration support — schisandrin C promotes hepatocyte proliferation and accelerates liver regeneration after partial hepatectomy in animal models (Zhu et al., 2000).